Home » Topics » Regulatory

Regulatory
RSS

Health Canada approves Asmanex Twisthaler for treatment of asthma

Dec. 12, 2000

Myobloc is first FDA-approved treatment for cervical dystonia

Dec. 11, 2000

FDA approves Protopic for the treatment of eczema

Dec. 11, 2000

Dimethaid receives approval for Pennsaid lotion in U.K.

Dec. 11, 2000

Testosterone buccal tablet enters late-stage clinical testing

Dec. 11, 2000

Cubist acquires rights to oral ceftriaxone

Dec. 4, 2000

Ziprasidone pharmaceutical formulations with good solubility properties

Nov. 30, 2000

FDA approves Lovenox for seventh indication

Nov. 22, 2000

FDA approves Boehringer Ingelheim's Micardis HCT

Nov. 21, 2000

New Tamiflu indication for prevention of influenza approved by FDA

Nov. 21, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...